Search
Amneal Pharmaceuticals Inc
AMRXAdd to Watchlist
20.160USD
+1.450+7.75%
Close 09-21 16:00（ET）
6.44BMarket Cap
51.99P/E TTM
After-hours 17:29 (ET)20.000USD-0.205-1.01%
After-hours 17:29 (ET)Amneal Pharmaceuticals Inc (AMRX) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Amneal Pharmaceuticals Inc in the past month.
Buy
1 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
21.537USD+15.11%
AMRX Analyst Recommendation Trends
In the current month, AMRX has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AMRX average Analyst price target in the last month is 21.537.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
0
0
0
0
0
0
0
4
4
5
5
5
5
5
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
4
5
5
5
5
5
4
AMRX Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Regeneron Pharmaceuticals Inc
REGN
6
15
11
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, AMRX EPS is projected to reach 0.230 in FY2026Q3, following reported EPS of 0.181 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.18
0.17
0.22
0.23
0.22
Actual
0.11
0.20
0.18
--
--
Surprise
-39.58%
+15.88%
-18.44%
--
--
FAQs
What is Amneal Pharmaceuticals Inc's expected revenue for the next quarter?
Amneal Pharmaceuticals Inc's expected revenue is 812.86M.
What is Amneal Pharmaceuticals Inc's price target?
Analysts forecast that Amneal Pharmaceuticals Inc's price target is USD 21.54, with the highest forecast at USD 25.00 and the lowest forecast at USD 19.22.
How have Amneal Pharmaceuticals IncAMRX's recent earnings per share performed?
The market expectation was USD 0.18, while Amneal Pharmaceuticals IncAMRX's earnings per share (EPS) for the previous quarter was USD 0.20. EPS for the next quarter is expected at USD 0.23.
What is the analyst rating for Amneal Pharmaceuticals Inc?
Based on the ratings of Amneal Pharmaceuticals Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.